Physician's Organization Makes History by Publishing U.S.'s First Adult Stem Cell Guidelines (ASCTA Drives Safe Stem Cell ...( The American...)

The American Stem Cell Therapy Association (ASCTA) announced today the availability of the world's first clinical guidelines to allow U.S. doctors to safely begin using a patient's own stem cells to treat disease.

Broomfield, CO (PRWEB) May 19, 2009 -- The American Stem Cell Therapy Association (ASCTA) announced today the availability of the world's first clinical guidelines to allow U.S. doctors to safely begin using the patient's own stem cells to treat disease.

ASCTA was formed in response to the FDA's position that the patient's own stem cells are considered drugs and should be regulated as such. Strong opposition by physicians and patients worldwide motivated the effort to research and publish scientific guidelines that provide the medical community with standards under which adult stem cell therapy can be practiced safely. These stem cell therapy guidelines represent the world's first clinical guidelines designed to facilitate safe stem cell therapy practice. A key aspect of the document is the concept that adult stem cell therapy with the patient's own cells is governed under the practice of medicine, not under drug production guidelines.        

Barbara Hanson, the founder of StemCellPioneers, stated, "We are very excited to see the progress of these guidelines. They form the blueprint for access to safe stem cell therapy here in the U.S. by millions of patients whose lives depend on new medical approaches to diseases and conditions."

Since the ASCTA's recent announcement that it was producing guidelines for care with stem cells, the organizat
'/>"/>